Growth Demand on Betulinic Acid Market Share are Rising by 2020-2025
Added: (Wed Aug 12 2020)
Pressbox (Press Release) -
Betulinic Acid Market 2020 Global Industry research report studies latest Betulinic Acid industry aspects market size, share, trends, growth, business overview and Betulinic Acid industry scenario during the forecast period (2020-2025).
Overview of Global Betulinic Acid Market:
Betulinic acid is a naturally occurring pentacyclic triterpenoid which has antiretroviral, antimalarial, and anti-inflammatory properties, as well as a more recently discovered potential as an anticancer agent, by inhibition of topoisomerase. It is found in the bark of several species of plants, principally the white birch (Betula pubescens) from which it gets its name, but also the ber tree (Ziziphus mauritiana), selfheal (Prunella vulgaris), the tropical carnivorous plants Triphyophyllum peltatum and Ancistrocladus heyneanus, Diospyros leucomelas, a member of the persimmon family, Tetracera boiviniana, the jambul (Syzygium formosanum), flowering quince (Pseudocydonia sinensis, former Chaenomeles sinensis KOEHNE), rosemary and Pulsatilla chinensis.
The report contains a complete product overview and its scope in the market to define the key terms and provide the clients a holistic idea of the market and its tendency. It comprehensively evaluates the global Betulinic Acid market with different perspectives for the purpose of providing a detailed, informative, and accurate analysis of regional growth, competition, market segmentation, and other important aspects.
Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/273652 .
Growth in the historic period resulted from economic growth in emerging markets, the rise in awareness of the benefits and developed nations towards Betulinic Acid costs and an increase in the number of selective inhibitor of human melanoma.
Product Type Segmentation:
The Betulinic Acid market have different product type such as Above 99%, Above 98% and Others. Betulinic Acid market product type gives apoptosis in human neuroblastoma in vitro and in vivo in model systems.
Industry Segmentation:
Increasing instances across various sectors such as Actinic Keratosis, Antiphlogistic Activity, Cancer, HIV and Other are raising the need of chemical institutes, thereby raising the demand for Betulinic Acid market. This help in the profitable growth of the Global Betulinic Acid market in upcoming year.
Segmentation by Regions:
The Betulinic Acid market in North America has created drug with assistance from the Rapid Access to Intervention Development program of the National Cancer Institute in the world. It was followed by Western Europe, China, Japan, Southeast Asia, India and Central & South America regions. Asia Pacific is expected to record higher growth rate in Betulinic Acid Market during the forecast year.
Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Betulinic Acid Market Report 2020” @ https://www.businessindustryreports.com/buy-now/273652/single .
Top Leading Key Manufacturers are: Aphios, Manus Aktteva Biopharma, Shaanxi Yuanyu Biological, FOODCHEM, Hangzhou Dayangchem, Wilshire Technologies, Simagchem Corporation, Capot Chemical, X´ian Taicheng Chem, Hangzhou Meite Chemical. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Top Industry News:
Aphios Granted US Patent for Combination HIV Latency Nanotherapeutic Towards an HIV Cure on 28 Jan, 2020 -- Aphios Corporation today announced that it was issued US Patent No. 10,493,030 for the treatment of HIV latency towards an HIV cure.
Since the start of the HIV/AIDS pandemic in 1982, over 32 million people have died from AIDS and there were approximately 37.9 million people living with HIV in 2018. In the United States, an estimated 1.1 million people are currently living with HIV and approximately 40,000 new infections occur each year. AIDS-related mortality has fortunately declined by 33% since 2010. Even with these encouraging statistics, the total number of persons infected increases about 1 million per year in the absence of a cure since the annual average rate of new infections is approx. 1.7 million and the average number of deaths globally is approx. 770,000. A cure for HIV is urgently needed to bend the curve towards ending this pandemic affecting more than 38 million people worldwide.
HIV infects several cell types during the course of infection and progression to AIDS. Antiretroviral (ART) is very effective in controlling replication of the virus in most cells. HIV, however, establishes latent long-term infection in a small pool of memory CD4+ T (immune) and other cells, which contain integrated but transcriptionally silent HIV provirus. These cellular virus reservoirs are a potential source of rapid HIV virus reactivation and progression to AIDS if ART is stopped for any reason. There are no commercially available drugs for treating HIV latency and/or curing HIV.
The Aphios ’030 patent is for a combination of two Latency Reversal Agents (LRAs) — a Protein Kinase C (PKC) modulator of the anti-tumor class, ‘Bryoids’ and a Histone Deacetylase (HDAC) inhibitor co-encapsulated in long-circulating pegylated immuno-nanosomes to purge latent HIV from cellular reservoirs. Bryoids, such as Bryostatin-1, activate cellular transcription factors such as NF-κB which transcribes latent HIV into active HIV virus. The HDAC inhibitor removes acetyl groups affecting gene expression and increases accessibility of NF-κB improving transcription efficacy. By combining a PKC modulator and HDAC inhibitor in the same nanoparticle, both drugs reach their intended target simultaneously. These nanoparticles can be coated with targeting ligands to reach their target and with anti-PDL-1 nanobodies to keep CD4+ T-cells activated for clearance of re-activated HIV-1 virus. These immuno-nanosomes will reduce systemic toxicities while pegylation increases nanoparticle biological residence time to increase therapeutic efficacy and overall therapeutic index.
Dr. Trevor P, Castor, CEO, Aphios and inventor of the issued patent states that “HIV/AIDS is a pandemic we are still battling on par with pandemics of the past such as the 14th century Bubonic Plague and the 20th century Spanish Flu. The end can sometimes seem to be a long way away, but a cure for HIV is realizable within our lifetime. APH-0812 is designed to activate latent HIV reservoirs for clearance by ARVs and/or the patient’s immune system, and eliminate the long-term economic burden of ARV drug costs, associated drug-induced side effects and social stigma.”
Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/273652 .
Major Points in Table of Contents:
1 Betulinic Acid Product Definition
2 Global Betulinic Acid Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Betulinic Acid Shipments
2.2 Global Manufacturer Betulinic Acid Business Revenue
2.3 Global Betulinic Acid Market Overview
3 Manufacturer Betulinic Acid Business Introduction
3.1 Aphios Betulinic Acid Business Introduction
3.1.1 Aphios Betulinic Acid Shipments, Price, Revenue and Gross profit 2020-2025
3.1.2 Aphios Betulinic Acid Business Distribution by Region
3.1.3 Aphios Interview Record
3.1.4 Aphios Betulinic Acid Business Profile
3.1.5 Aphios Betulinic Acid Product Specification
3.2 Manus Aktteva Biopharma Betulinic Acid Business Introduction
3.2.1 Manus Aktteva Biopharma Betulinic Acid Shipments, Price, Revenue and Gross profit 2020-2025
3.2.2 Manus Aktteva Biopharma Betulinic Acid Business Distribution by Region
3.2.3 Interview Record
3.2.4 Manus Aktteva Biopharma Betulinic Acid Business Overview
3.2.5 Manus Aktteva Biopharma Betulinic Acid Product Specification
3.3 SHAANXI YUANYU BIOLOGICAL Betulinic Acid Business Introduction
3.3.1 SHAANXI YUANYU BIOLOGICAL Betulinic Acid Shipments, Price, Revenue and Gross profit 2020-2025
3.3.2 SHAANXI YUANYU BIOLOGICAL Betulinic Acid Business Distribution by Region
3.3.3 Interview Record
3.3.4 SHAANXI YUANYU BIOLOGICAL Betulinic Acid Business Overview
3.3.5 SHAANXI YUANYU BIOLOGICAL Betulinic Acid Product Specification
3.4 FOODCHEM Betulinic Acid Business Introduction
3.5 HANGZHOU DAYANGCHEM Betulinic Acid Business Introduction
3.6 Wilshire Technologies Betulinic Acid Business Introduction
………………. Request free sample to get a complete Table of Content
About us
BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.
Media Contact
Business Industry Reports
Pune – India
sales@businessindustryreports.com
+19376349940